Stocktoria
Black Diamond Therapeutics, Inc. BDTX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-01-30
Black Diamond Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,217,128 | $15.0M | 5.59% |
| RENAISSANCE TECHNOLOGIES LLC | 1,643,747 | $3.5M | 2.86% |
| CITADEL ADVISORS LLC | 604,552 | $1.3M | 1.05% |
| D. E. Shaw & Co., Inc. | 363,921 | $775,152 | 0.63% |
| MILLENNIUM MANAGEMENT LLC | 134,979 | $287,505 | 0.23% |
| Point72 Asset Management, L.P. | 100,985 | $215,098 | 0.18% |
| TWO SIGMA INVESTMENTS, LP | 43,300 | $92,229 | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.